IMNM vs REG · $2.47B cap vs P/E 34, rev $1.45B
Immunome Inc (IMNM) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Immunome Inc (IMNM) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported IMNM revenue for 2026-06-30 was $0. Net income was -$127.0M. IMNM currently screens at market cap $2.47B.
Latest reported REG revenue for 2024-12-31 was $1.45B. Net income was $409.8M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
IMNM currently screens at market cap $2.47B. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the IMNM and REG stock pages for the full models.
Not investment advice.